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Cottontail rabbit papillomavirus (CRPV) induces rabbit skin papillomas, which progress to invasive carcinoma in some
animals. Two early genes, E7 and E6, have been demonstrated previously to be oncogenes. In this study, we identified two
additional transforming genes, E8 and E5. Both E8 and E5 stimulated C127 and BALB/c A31 (A31) cell proliferation and
affected cell cycle transition. The E8 and E5 transfectants lost cell contact inhibition, reaching a high saturation density when
cultured up to 2 weeks. E8–C127 transfectants formed colonies in soft agar in the presence of platelet-derived growth factor
(PDGF) while E5–C127 transfectants formed colonies without the requirement for PDGF. E8–C127 transfectants were highly
tumorigenic whereas E5–C127 transfectants showed a weak tumorigenicity in nude mice. Both E8 and E5 A31 transfectants
failed to form colonies in soft agar even in the presence of platelet-derived growth factor (PDGF) and did not develop tumors
in nude mice. These results clearly showed that CRPVE8 and E5 are oncogenes and that the PDGF b-receptor signaling
pathway may be involved in E8-mediated C127 cell transformation. The difference in colony formation in soft agar and
tumorigenicity in nude mice between C127 and A31 cell lines indicates that additional alterations in cellular gene expression
are needed for E5- and E8-transfected cells to acquire a malignant phenotype. © 1998 Academic Press
INTRODUCTION
Papillomaviruses are widespread among vertebrate
species and induce cutaneous or mucosal lesions that
may progress to carcinoma (Orth, 1987; Wettstein et al.,
1987; zur Hausen, 1994). Three independent open read-
ing frames (ORFs), E7, E6, and E5, have been demon-
strated to encode transforming proteins. Each gene
transforms cells via different mechanisms. E7 and E6 of
high-risk human papillomaviruses (HPVs) are major
transforming genes that counteract cellular tumor sup-
pressor genes retinoblastoma (Rb) (Barbosa et al., 1990;
Mu¨nger et al., 1989a, 1989b; Phelps et al., 1988) and p53
(Crook et al., 1991; Kessis et al., 1993; Li and Coffino,
1996; Scheffner et al., 1990; Werness et al., 1990), respec-
tively. The E5 of bovine papillomavirus type 1 (BPV-1) is a
major transforming gene in BPV-1-mediated transforma-
tion of rodent fibroblasts and activates the endogenous
platelet-derived growth factor (PDGF) b-receptor signal-
ing pathway (Bergman et al., 1988; Burkhardt et al., 1987;
DiMaio et al., 1986; Groff and Lancaster, 1986; Schiller et
al., 1986; Schlegel et al., 1986; Yang et al., 1985). The E5
of certain HPV types can also transform rodent fibro-
blasts through interaction with cell surface growth factor
receptors that initiate tyrosine-specific protein kinase
signaling pathway (Bouvard et al., 1994; Chen and
Mounts, 1990; Conrad et al., 1994; Leechanachai et al.,
1992; Pim et al., 1992; Straight et al., 1993).
Cottontail rabbit papillomavirus (CRPV) induces skin
tumors in its native host, the cottontail rabbit, as well as
in domestic rabbits under experimental conditions (Kre-
ider and Bartlett, 1985). The CRPV genome consists of
seven early genes, E1, E2, E4, E5, E6, E7, and E8, and two
late genes, L1 and L2. CRPV E6 and E7 are also onco-
genic. They can transform NIH 3T3 cells in vitro (Harry
and Wettstein, 1996; Meyers et al., 1992; Schmitt et al.,
1994) and are required for papilloma formation in vivo
(Brandsma et al., 1991; Meyers, 1992; Wu et al., 1994).
However, neither CRPVE5 nor E8 transforms NIH3T3
cells in vitro (Harry and Wettstein, 1996; Meyers, 1992).
CRPVE8 is colinear with E6 and encodes a hydrophobic
polypeptide with 50 amino acids. CRPVE5 is located in
the 39 region of the CRPV early gene region and encodes
a polypeptide with 101 amino acids (Giri et al., 1985).
Amino acid sequence comparison of CRPVE8 and E5
with BPV-1E5 indicates that CRPVE8 shares a significant
structural similarity with BPV-1E5. CRPVE8 therefore may
demonstrate similar functional activities to BPV-1E5, al-
though it is unable to transform NIH 3T3 cells alone.
Mutations in the CRPV DNA that abolished E5 expres-
sion reduced the efficiency of papilloma induction and
papilloma volume in New Zealand White rabbits
(Brandsma et al., 1992; Meyers, 1992). These observa-
tions indicate that CRPV E5 contains some important
unknown biological function.
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To further characterize the function of CRPVE8 and E5,
we cloned CRPVE8 and E5 genes into mammalian ex-
pression vector, pcDNA3, and transfected them into two
rodent fibroblast cell lines, C127 cells and BALB/c A31
cells (A31). We examined cell growth rates, cell cycle
transition, anchorage-independent growth in soft agar,
and tumorigenesis in nude mice. The data from these
experiments demonstrated the cellular transforming ac-
tivities of CRPVE8 and E5.
RESULTS
CRPVE8 and E5 nucleotide sequences
The full sequence of one isolate of CRPV has been
published and is defined as the Kansas strain CRPV-KA
(Giri, 1985). However, an isolate of CRPV (CRPV-HE) was
independently cloned at Hershey from a different stock
of Kansas-derived CRPV (Kreider and Bartlett, 1985). We
therefore sequenced E8 and E5 genes of this isolate. We
also sequenced E8 and E5 genes that were amplified by
PCR and cloned in pcDNA3 vector. The nucleotide se-
quences of E5 or E8 genes in pcDNA3 vector were
identical to the cloned CRPV-HE, indicating no PCR-
introduced mutations. In comparison with the fully se-
quenced CRPV-KA (Giri, 1985), CRPV-HE E8 has only one
silent nucleotide mutation at codon 24 (C3A). In con-
trast, the insert, deletion, and frameshift mutations were
found in the CRPV-HE E5 gene; these included (1) three-
nucleotide insertion at codon 24 (TTT, Phe), (2) three-
nucleotide deletion at position 30 (CAT, His), (3) one-
nucleotide transition at codon 29 (A3T), which does not
induce an amino acid change, and (4) an insertion of two
nucleotides at codon 33 (CA), which induces a frameshift
mutation that changes the remaining downstream amino
acid sequence (Figs. 1A and 1B). These mutations result
in CRPV-HE E5 encoding a 62-amino-acid protein that
contrasts to the 101-amino-acid E5 of CRPV-KA. The
second polyadenylation signal is located downstream of
the E5 stop codon. Brandsma et al. (1992) sequenced the
E5 gene of an additional isolate, referred to as Washing-
ton strain, CRPV-WA, and found one codon deletion, two
insertions, and one transition mutation. These nucleotide
variations in CRPV-WA resulted in 10 contiguous noncon-
servative amino acid changes between codons 24–33
(Fig. 1) but preserved an intact E5 ORF of 100 amino
acids. Alignment of nucleotide and amino acid sequence
of the E5 genes of three CRPV strains (or isolates) dem-
onstrated significant variation (Fig. 1).
Translation of CRPVE8 and E5 proteins in vitro
We conducted in vitro translation experiments to check
CRPVE8 and E5 protein production from the recombinant
plasmids pcDNA3/CRPVE8 and pcDNA3/CRPVE5. In this
study, CRPVE8 and E5 were translated in vitro in the pres-
ence of canine pancreatic microsomes. CRPVE8 encodes a
50-amino-acid hydrophobic polypeptide. It shares structural
similarity with BPV-1E5, which has been demonstrated to
be a membrane protein (Burkhardt et al., 1989; Schiller,
1986). CRPVE8 was efficiently translated in vitro (Fig. 2A,
lane 1) and was presented in microsomes (Fig. 2A, lane 3).
CRPV-HE E5 encodes 62 amino acids. The NH2-terminal
third of CRPV E5 is slightly hydrophobic, and the remaining
two thirds are hydrophilic. CRPV E5 could also be observed
in solubilized microsomes (Fig. 2A, lane 4). CRPV E5 had a
very low translation efficiency as shown by the very weak
signal in the starting material lane (Fig. 2A, lane 2). In the
FIG. 1. Alignment of partial nucleotide and full amino acid sequences of E5 from CRPV-KA, CRPV-WA, and CRPV-HE. (A) Nucleotide variation in three
CRPV isolates between codons 23–34. Polyadenylation motifs are underlined. Bold letters represent nucleotide insertion. Dashed line represents
nucleotide deletion. Italic and underlined letters represent nucleotide transitions. (B) Amino acid alignment. Amino acids are noted by standard
one-letter symbols. Dashes represent amino acids identical to the topmost sequence.
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absence of microsomes, E5 protein was undetectable in
our in vitro translation experiments (data not shown). Inter-
estingly, both E8 and E5 proteins migrated substantially
slower than that anticipated in SDS–PAGE (Fig. 2A). Previ-
ous reports have demonstrated similar retardation of E5
products. One suggestion has been the possible dimeriza-
tion of E5 despite the presence of SDS and b2-mercapto-
ethanol (Kell et al., 1994; Mayer and Meyers, personal
communication). Alternatively, the E5 and E8 proteins may
have some other unusual properties.
CRPVE8 and E5 expression in C127 and A31
transfectants
To examine E8 and E5 gene expression in the transfec-
tant cell lines C127E8, C127E5, A31E8, and A31E5 cells,
total RNA was extracted. E8- and E5-specific mRNA was
undetectable by Northern blot hybridization using 20 mg of
total RNA per lane. Thus RT-PCR was conducted to amplify
E8 and E5 transcripts. After DNase I digestion, PCR ampli-
cation of the RNA extracted from E8 and E5 transfectants
showed a band corresponding to the E8 gene (150 bp plus
20 bp from primers) or the E5 gene (303 bp plus 20 bp from
primers) (Fig. 2B, lanes 1, 2, 4, and 5). In contrast, after
RNase digestion, none of the E8 and E5 specific bands
were observed in PCR amplification products. These re-
sults indicated that both E8 and E5 were expressed in their
transfectants but at low levels.
Morphological transformation of C127 and A31 cells
by CRPVE8 and E5
The CRPVE8 and E5 transfectant cell lines C127E8,
C127E5, A31E8, and A31E5 rapidly acidified the cell cul-
ture medium. Compared with vector transfectants, E8
and E5 transfectant cells were refractive, smaller in size,
and contained spindle-shaped cells (Figs. 3Ab, 3Ac, 3Ae,
and 3Af). E8 and E5 transfectant cells lost contact inhi-
bition, reaching a high saturation density (Figs. 3Ab, 3Ac,
3Ae, and 3Af). The C127 transfectant cell lines C127E8
and C127E5 reached similar high saturation densities
(Figs. 3Ab and 3Ac), as did A31E8 and A31E5 transfec-
tant cell lines (Figs. 3Ae and 3Af). However, the satura-
tion density of the C127E8 and C127E5 cells was higher
than that of the A31E8 and A31E5 cells.
When the cell lines C127E8, C127E5, A31E8, and
A31E5 were cultured for .2 weeks, many high-density
regions appeared that were distributed throughout the
monolayer cells (Figs. 3Bb, 3Bc, 3Be, and 3Bf). The mor-
phology of these high-density regions was different from
typical C127 foci induced by BPV-1 infection, which are
characterized by overlapped growth of spindle-shaped
cells (data not shown). In this study, only a few spindle-
shaped cells could be seen around a high-density re-
gion. Nevertheless, staining with crystal violet clearly
showed a heterogeneous growth of C127E8 (Fig. 3Bb),
C127E5 (Fig. 3Bc), A31E8 (Fig. 3Be), and A31E5 (Fig. 3Bf),
indicating areas of overlapped growth. The high-density
regions of A31E8 had well-defined borders (Fig 3B).
CRPVE8 and E5 proteins are mitogenic
E8 and E5 transfectant cells grew much faster than
control vector transfectant cells, indicating that CRPVE8
and E5 are mitogenic for rodent fibroblasts. Although E8
and E5 transfectants were not distinguishable by their
morphology in short-term culture, their growth kinetics
were different. Figure 4A shows that C127E8 cells grew
faster than C127E5 cells in the early phase of culture
(from day 1 to day 8). In the late phase (day 9 to day 14),
C127E5 cells grew faster than C127E8 cells. This may
have occurred because E8 transfectant cells reached
saturation density more quickly than the E5 transfectants
FIG. 2. (A) In vitro translation of pcDNA3/CRPVE5 and pcDNA3/
CRPVE8. CRPVE8 and E5 were translated in vitro in the presence of
canine pancreatic microsomes. After a 90-min reaction, 5 ml was taken
out from 25 ml of reaction solution and subjected to 15% SDS–PAGE.
Microsomes then were pelleted and washed with PBS. Solubilized
microsomes were subjected to 15% SDS–PAGE. Lanes 1 and 2 show
starting materials; lanes 3 and 4, solubilized microsomes; and lane 5,
vector control. Samples are marked on the top, and the molecular mass
is indicated on the left. (B) Detection of E8 and E5 transcripts in E8 and
E5 transfectants by RT-PCR. Total RNA was extracted with Trizol re-
agent. RNA was digested with DNase I or RNase, respectively, and
then subjected to RT-PCR, first with oligo(dT) primer and then with E8-
and E5-specific primers. A band corresponding to the E8 gene was
observed in lanes 1 (C127E8) and 4 (A31E8), and a band corresponding
to the E5 gene was observed in lanes 2 (C127E5) and 5 (A31E5). The
vector transfectants (lanes 3 and 6) and RNase-treated samples (lanes
7–10) did not show these bands. Samples are marked on the top of the
gel, and molecular weight markers are shown on the left.
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FIG. 3. (A). Morphological transformation of C127 and BALB/c 3T3 A31 cells by CRPVE8 and E5. Cells were cultured for 10 days. CRPVE5 and E8
transfectants are refractive and smaller in size, and some are spindle shaped. They grew in high density. a shows C127V; b, C127E8; c, C127E5; d,
A31V; e, A31E8; and f, A31E5. Magnification 3300. (B) Foci of CRPVE8 and E5 transfectants. Cells were cultured for 15 days and then fixed in 10%
neutral buffered Formalin and stained with 0.1% crystal violet. When compared with vector transfectants, E8 and E5 transfectants showed a
heterogeneous growth. Dark regions represent the overlapping growth of cells. a shows C127V; b, C127E8; c, C127E5; d, A31V; e, A31E8; and f, A31E5.
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cells. Finally, C127E8 and C127E5 transfectants had sim-
ilar saturation densities, which were ;3-fold higher than
that of C127V cells. The impact of CRPVE8 and E5 on A31
proliferation was similar to that of C127 cells (Fig. 4B).
The saturation density of A31E8 and A31E5 cells was
;2-fold that of A31V cells.
CRPVE8 and E5 affect cell cycle transition
Cells at logarithmic growth phase were collected and
subjected to DNA content analysis by flow cytometry.
The distribution of cells in G0 1 G1, S, and G2 1 M
phases was determined with CELLFIT software. Several
repeat experiments were conducted. CRPVE8 and E5
transfectant cells always contained more cells in S
phase than vector transfectant cells. Figure 5 shows the
results of one experiment. C127V had only 11.6% cells in
S phase, whereas C127E5 and C127E8 had 26.6% cells
and 27.2% cells in S phase, respectively. The number of
A31E5 cells (9.6%) and A31E8 cells (14%) in S phase was
;2-fold of the number of A31V cells in S phase (5.4%).
Theoretically, both an enhancement in transition from G1
to S phase or a delay in transition from S phase to G2/M
phase can induce an increase in S phase cells. Because
CRPVE8 and E5 transfectants have higher growth rates
than vector transfectant cells, it is likely that CRPVE8 and
E5 promote G1/S transition rather than S phase delay, in
which cell growth rates should be decreased.
Anchorage-independent growth
Because BPV-1E5 transforms rodent fibroblasts via
PDGF receptor signaling transduction pathway and BPV-
1E5 has a similar hydropathy profile to CRPVE8, we
tested anchorage-independent growth of CRPVE8 and
E5 transfectant cells in soft agar in the presence or
absence of PDGF (see Materials and Methods). In this
study, C127V cells did not form colonies in soft agar in
the absence of PDGF and formed a few colonies in the
presence of PDGF (,5 colonies/60-mm dish). C127E8
cells formed a few colonies in the absence of PDGF (,5
colonies/60-mm dish) but several hundred colonies in
the presence of PDGF (Table 1). These results indicated
that CRPVE8 is involved in the PDGF receptor signaling
pathway, and the anchorage-independent growth of
C127 cell lines required the presence of both exogenous
PDGF receptor ligand and CRPVE8. C127E5 cells formed
colonies without exogenous PDGF, and added PDGF did
not increase the number of colonies (Table 1). Although
CRPVE8 and E5 stimulated A31 cell proliferation and
induced morphological changes, A31E8 and A31E5 cells
did not grow colonies in soft agar, even in the presence
of PDGF (Table 1).
Tumorigenesis in nude mice
All three nude mice injected with C127E8 cells devel-
oped tumors (Fig. 6A). One of three nude mice injected
with C127E5 cells developed a small tumor (Fig. 6B); this
was unexpected because the ability of the anchorage-
independent growth of C127E5 was much stronger than
that of C127E8. None of three control mice injected with
C127V cells developed tumors (Fig. 6C). No tumor grew
in mice injected with A31E8, A31E5, and A31V cells.
DISCUSSION
In this study, we demonstrated that both CRPVE8 and
E5 transformed C127 cells. We also showed that CRPVE8
and E5 stimulated BALB/c 3T3 A31 cell proliferation and
induced morphological changes, although the latter
transfectants failed to grow in soft agar and failed to
develop tumors in nude mice. These results indicate that
CRPVE8 and E5 are weak transforming genes.
The mechanism or mechanisms by which CRPVE8
and E5 transform rodent fibroblasts are unknown. In
addition to the experiments described in the results
section, we attempted immunoprecipitation of CRPVE8
from the transfectant cell lines. To accomplish these
studies, we added an antigenic epitope (FLAG, DYKD-
DDDK) at the N terminus of CRPVE8 (CRPVE8 59 FLAG)
and at the C terminus (CRPVE8 39 FLAG), respectively.
FIG. 4. Cell growth curve. Cells (2 3 104) were plated onto 35-mm
dishes, and medium was changed twice weekly. Cells were collected
and counted every other day. (A) Growth curve of C127E8, C127E5, and
C127V. (B) Growth curve of A31E8, A31E5, and A31V. Two additional
growth curve experiments showed similar trends.
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The addition of FLAG to the N terminus of CRPVE8 did
not change its biological function, but the addition of
FLAG to the C terminus of CRPVE8 destroyed its mito-
genic function (data not shown). However, we were un-
able to precipitate CRPVE8 59 FLAG using FLAG-reactive
monoclonal antibody. A comparison of the hydropathy
profiles of BPV-1E5, CRPVE8, and E5 reveals that all
three proteins have a hydrophobic N terminus of ;25
amino acids (Fig. 7). Both BPV-1E5 and CRPVE8 are
leucine rich and have relatively hydrophobic C termini. In
contrast, CRPV-HE E5 has a long hydrophilic C terminus
that is not observed in other papillomavirus E5 proteins.
These structural characteristics suggest that CRPVE8
transforms C127 cells via a similar mechanism to BPV-
1E5. In support of this assumption, we found that PDGF
was required for anchorage-independent growth of
CRPVE8-transfected C127 cells, indicating an involve-
ment of PDGF receptor in transforming C127 cells. These
observations also indicated that CRPVE8 alone could not
efficiently activate the PDGF receptor. Because PDGF
alone also did not induce C127 cell anchorage-indepen-
dent growth, CRPVE8 must greatly facilitate PDGF recep-
tor activation and signal transduction on ligand binding.
The CRPV-HE E5-induced transformation phenotype
was different than that induced by CRPVE8 as deter-
mined by differences in anchorage-independent growth
and tumorigenesis in nude mice. CRPVE5 transfectant
cells formed colonies more efficiently than CRPVE8
transfectants in soft agar and did not need PDGF. How-
ever, CRPVE5 transfectants had weak tumorigenicity in
nude mice compared with CRPVE8 transfectants. These
observations suggest that CRPV E5 transforms C127
cells via a mechanism different from that used by
CRPVE8. The presence of a hydrophobic N terminus of
the CRPV-HE E5 protein raises the possibility that E5 is
a membrane-associated protein. The presence of CRPV
E5 in microsomes after in vitro translation supports this
assumption. Because the sequence of E5 protein from
the Hershey isolate was significantly different from that
observed for previously sequenced E5 proteins (Fig. 1), it
is possible that the transforming activities of CRPVE5 in
our studies may be specific to CRPV-HE E5 protein.
Two polyadenylation signals (AATAAA) are located in
the CRPV E5 ORF (Giri et al., 1985). The first one is
located between codons 25–27 of E5, and the second is
located between codons 65–67. AAUAAA in primary
FIG. 5. Flow cytometric histograms of DNA content of E8 and E5 transfectants as well as vector transfectants. Cells at logarithmic growth phase
were collected and fixed in 75% ethanol. Cellular RNA was digested with RNase, and DNA was stained with PI. DNA content was analyzed by using
FACScan. Cell cycle distribution was determined using CELLFIT software. High peak: G0–G1 phase; lower peak: G2–M phase; between two peaks:
S phase. a shows C127V; b, C127E8; c, C127E5; d, A31V; e, A31E8; and f, A31E5.
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hnRNA is the binding site for the cleavage and polyad-
enylation specificity factor (CPSF) (Sachs and Wahls,
1993). The primary hnRNA transcript is cleaved at a point
within 30 nucleotides downstream of an AAUAAA motif
and just upstream of a GU-rich segment that shows less
sequence conservation (Jackson and Standart, 1990).
RNA mapping has revealed that CRPV early gene tran-
scription stops at the first polyadenylation signal
(Wettstein, 1990). If E5 is translated from a transcript
cleaved downstream of the first poly(A)1 signal, then the
E5 gene would encode only ;30 amino acids. It will be
interesting, therefore, to determine whether the first 30
amino acids of E5 have functional activity. However, it
also is possible that some CRPV early transcripts are
cleaved downstream of the second poly(A)1 signal. In
the latter situation, the 62-amino-acid polypeptide will be
fully translated from the CRPV-HE E5 gene. In our study,
the cloned E5 gene in pcDNA3 vector may be expressed
as three different mRNA species using three different
polyadenylation signals. The first two would use the
poly(A)1 signals within the E5 ORF. The third mRNA
would use the vector poly(A)1 signal. However, the entire
E5 ORF was amplified from the RT products using E5 59
and 39 primers, indicating the existence of E5 mRNA
containing the poly(A)1 signal from vector. The two
smaller mRNA E5 species also may be present in the E5
transfectants. Further genetic studies are needed to dis-
sect the functional domains of CRPV E5 proteins. Loca-
tion of polyadenylation signals in the middle of the E5
gene has led to the suggestion that CRPVE5 may not be
expressed in vivo and may play no role in papilloma
induction in vivo (Wettstein, 1990). However, CRPV DNA
with several E5 mutations reduced the efficiency of pap-
illoma induction and growth rates in domestic rabbits
(Brandsma, 1992; Meyers, 1992). These data are consis-
tent with our observations that CRPV E5 has proliferative
activity.
Harry and Wettstein (1996) transfected the CRPVE8
gene into NIH3T3 cells and did not observe transforma-
tion. There are two possibilities to explain these results,
which contradict our studies. First, in the earlier report,
PDGF was not added to the culture medium used for the
soft agar assay. We clearly showed in the present study
that an anchorage-independent growth of the CRPVE8
transfectant requires PDGF. Second, differences in an-
chorage-independent growth could result from the differ-
ent growth properties of NIH3T3 cell lines and C127 cell
lines. Sparkowski et al. (1996) demonstrated that muta-
tion of some amino acids of BPV-1E5 can greatly de-
crease or even abolish the ability of these mutants to
transform NIH3T3 cells but does not affect their ability to
transform C127 cells.
Our data clearly showed different transforming pheno-
types of C127 and A31 cells by CRPVE8 and E5. Alter-
ation of cellular gene expression or differential expres-
sion of some cellular genes in C127 and A31 cells should
account for these differences. Although we do not know
exactly which gene or genes are responsible for these
differences, we know that C127 cells express only PDGF
b-receptor (Petti and DiMaio, 1994), whereas BALB/c 3T3
A31 cells express both PDGF a- and b-receptors (Clae-
sson-Welsh, 1994; Diliberto et al., 1992). Therefore, if
CRPVE8 can interact with both PDGF a- and b-receptors,
such interaction might interfere with the PDGF b-recep-
tor signaling transduction and prevent fully malignant
transformation of A31 cells. Diliberto et al. (1992) re-
ported that the simultaneous activation of the PDGF
a-receptor can inhibit PDGF b-receptor mediated re-
lease of Ca21, which is very important for many intracel-
lular molecular interactions.
In summary, we found that CRPVE8 and E5 stimulated
rodent fibroblast proliferation, promoted cell cycle tran-
sition, and induced anchorage-independent growth and
that CRPVE8- and E5-transfected C127 cells were tumor-
igenic in nude mice. These data indicated that CRPVE8
and E5 are oncogenes.
MATERIALS AND METHODS
Recombinant plasmid constructions
E5 and E8 genes of our CRPV isolate, described as
CRPV Hershey Strain, CRPV-HE, were amplified by PCR
for 20 cycles using Vent DNA polymerase as described
by the manufacturer (Biolab, Beverly, MA). Two oligonu-
cleotides, 59-CGG GAT CCC GAT GGG CTT TAG TGA
CGT GTA TGC A-39 and 59-CGG GAT CCC GCT AGT CGA
CCC CCA GAA CCT C-39 were used as primers to am-
plify the E5 gene, and two oligonucleotides, 59-CGG GAT
CCC GAT GGG ACC TGC AGA GAC TGC A-39 and 59-
CGG GAT CCC GCT GGA ATA GTT AAT CTT CTT CCG
C-39, were used to amplify the E8 gene. The PCR frag-
TABLE 1
Anchorage-Independent Growth of CRPVE8 and E5 Transfectants
Cells
Exp. 1 Exp. 2
PDGF1 PDGF2 PDGF1 PDGF2
C127V 1 2 1 2
C127E5 1111 1111 1111 1111
C127E8 111 1 111 1
A31V 2 2 2 2
A31E5 2 2 2 2
A31E8 2 2 2 2
Note. Anchorage-independent growth of CRPVE8 and E5 transfec-
tants. 1 3 105 cells were suspended in 3 ml medium containing 0.3%
Noble agar and plated on the top of the bottom layer of 0.5% Noble agar
in medium. PDGF was added to medium at a concentration of 12.5
ng/ml where indicated. Cells were fed twice weekly with 1 ml of
medium and scored for colony formation after 4 weeks. Those colonies
whose diameter greater about five time larger than that of individual
cell were counted. 1: ,5 colonies/60-mm dish; 111: 100–250 colo-
nies/60-mm dish; 1111: .250 colonies/60-mm dish.
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ments were cloned into the pcDNA3 vector (InVitrogen,
San Diego, CA) at the BamHI site. Orientation was con-
firmed by DNA sequencing. The resultant plasmids are
referred to as pcDNA3/CRPVE5 and pcDNA3/CRPVE8,
respectively.
DNA sequencing
All DNA sequencing was conducted in the Macromo-
lecular Core Facility of the Hershey Medical Center on a
model 377 ABI Prism sequencer. CRPV E5 gene in four
clones of CRPV-HE in pUC19 at the SalI site were se-
quenced using either M13 forward or reverse primers
depending on the orientation of the genome within the
vector. In addition, the E5 and E8 genes in pcDNA3 were
sequenced using both Sp6 and T7 primers. All runs
produced identical sequences.
In vitro translation of CRPV E5 and E8 proteins
In the present study, in vitro translations were per-
formed with the TNT coupled reticulocyte lysate system
(Promega, Madison, WI) in the presence of canine pan-
creatic microsome membranes (Promega) at 30°C for 90
min. Typical translation reactions contained 12.5 ml of
TNT rabbit reticulocyte lysate, 1 ml of TNT reaction buffer,
FIG. 6. Tumorigenesis of C127E8 and C127E5 in nude mice. Cells were collected at logarithmic growth phase and suspended in PBS. Cells (5 3
106) in 0.1 ml of PBS were subcutaneously injected into nude mice. Each cell line was injected into three mice. Mice were killed at 8 weeks and
photographed. (A) C127E8-injected mice. (B) C127E5-injected mice. (C) C127V-injected mice.
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0.5 ml of TNT RNA polymerase, 0.5 ml of 1 mM amino acid
mixture minus methionine, and 2.0 ml of 35S-methionine
containing 20 mCi (Amersham SJ1050, 1000 Ci/mmol), 0.5
ml/20 Ur RNasin ribonuclease inhibitor (Promega), 1.8 ml
of canine microsome, and 0.5 mg of DNA dissolved in 6.2
ml of RNase-free water (total reaction volume, 25 ml).
After incubation for 90 min, 5 ml was taken out and kept
on ice for SDS–PAGE. The remaining 20 ml of reaction
solution was centrifuged at 14,000 rpm in a microcentri-
fuge to pellet microsomes. Microsomes were washed
twice with 13 PBS and then solubilized with 10 ml of lysis
buffer (150 mM NaCl, 50 mM Tris–HCl, pH 8.0, 5 mM
EDTA, 1% Triton X-100) containing protease inhibitors, 3.6
mg/ml Aprotinin (Sigma Chemical, St. Louis, MO), and
100 mg/ml phenylmethylsulfonyl fluoride (Sigma). Next, 5
ml of starting material before microsome pelleting and 10
ml of solubilized microsomes were subjected to SDS–
PAGE after heating in a boiling water bath for 5 min with
an equal volume of 23 SDS sample loading buffer (120
mM Tris–HCl, 20% glycerol, 4% SDS, 2% b2-mercapto-
ethanol, and 2% bromphenol blue). Gels were subse-
quently fixed in methanol–acetic acid–glycerol (30:10:1%
vol/vol), soaked in Enlighting (DuPont, Boston, MA),
dried, and exposed to Kodak XAR-5 film for varying times
at 280°C.
Cell culture and DNA transfection
C127 cells were maintained in DMEM supplemented
with 5% (vol/vol) FBS (Irvine Scientific, Santa Ana, CA).
A31 cells were obtained from American Type Culture
Collection (Rockville, MD). A31 cells were maintained in
DMEM supplemented with 10% (vol/vol) newborn calf
serum (JRH Bioscience, Lenexa, KS). A modified calcium
phosphate method was used for transfection of plasmid
DNA into A31 or C127 cells (Chen and Okayama, 1987).
Briefly, cells used for DNA transfection were plated at
;70% confluence in T-25 flasks. Next, 10 mg of circular
plasmid DNA was added to 500 ml of 0.25 M CaCl2
solution. This DNA–CaCl2 solution was gradually added
to 500 ml of HEPES-buffered saline, pH 7.10, with mixing.
This mixture was allowed to incubate at room tempera-
ture for 20 min and then added to cell culture medium,
and the cells were incubated at a 37°C, 5% CO2 atmo-
sphere. After 7 h, the cells were shocked with 10%
dimethylsulfoxide in PBS. Neomycin-resistant selection
began 24 h after dimethylsulfoxide shock by the addition
of 500 mg/ml neomycin (GIBCO, Rockville, MD). G418-
resistant colonies were pooled after a 2-week selection
and maintained with medium containing 200 mg/ml neo-
mycin. Six cell lines, C127-pCDNA3/CRPVE5 (C127E5),
FIG. 7. Hydropathy profile and amino acid sequence of BPV-1E5, CRPVE8, and CRPVE5. The hydropathy profiles were generated with DNASIS
software (Version 2.1) using Kyte and Doolittle values. The hydrophobic region is indicated in the plus area, whereas the hydrophilic region is indicated
in the minus area.
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C127-pCDNA3/CRPVE8 (C127E8), C127-pCDNA3 (C127V),
A31-pCDNA3/CRPVE5 (A31E5), A31-pCDNA3/CRPVE8
(A31E8), and A31-pCDNA3 (A31V), were established from
the expansion of these pooled colonies. These cell lines
were used for this study.
RNA analysis
Total RNA was extracted from CRPVE8, E5, and vector
transfectants with Trizol reagents (Life Technologies). To
remove contaminating DNA, 2 mg of total RNA extracted
from each transfectant was digested with DNase I (am-
plication grade; Life Technologies) for 15 min at room
temperature. DNase I was inactivated by heating at 65°C
for 15 min in the presence of 2.5 mM EDTA. The reaction
mixtures were directly subjected to RT for synthesis of
cDNA with oligo(dT) primer and Molony murine leukemia
virus reverse transcriptase (Promega). An additional 2 mg
of total RNA of C127E8, C127E5, A31E8, and A31E5 was
treated with RNase One Ribonuclease (Promega) to di-
gest RNA. The reaction mixtures were extracted with 10
volumes of Trizol, and the final ethanol-precipitated prod-
uct was dissolved in 5 ml of water and subjected to PCR
amplification with E8- and E5-specific primers. We used
5 m of 25 ml of RT PCRs to amplify E5 or E8 transcripts for
30 cycles with E5- or E8-specific primers. A second
round of 30 PCR cycles was conducted, and 15 ml of this
reaction product was analyzed in a 1% agarose gel.
Cell growth rates and cell cycle analysis
Cells (2 3 104) were plated onto replicate 35-mm
dishes, and the medium was changed twice weekly.
Separate cultures of cells were collected and counted
every 2 days. For cell cycle analysis, cells at logarithmic
growth phase were trypsinized and counted. Cells were
washed once with 13 PBS containing 1% D-glucose,
resuspended in 75% ethanol, and stored in the refriger-
ator until further analysis. For flow cytometric analysis,
cells in 75% ethanol were centrifuged at 500g for 5 min.
The ethanol was carefully poured off, and the cells were
resuspended at 2 3 106/ml in propidium iodide (PI)
solution (13 PBS with 1% D-glucose, 50 mg/ml PI, 25
mg/ml RNase) at room temperature for .30 min to digest
cellular RNA and stain DNA with PI. DNA content was
analyzed by using FACScan (Becton & Dickinson). Cell
cycle distribution was determined using CELLFIT Soft-
ware (Becton & Dickinson, Version 2.0.2). A total of 2.5 3
104 cells were analyzed for each cell line.
Anchorage-independent growth assays
Six cell lines, C127E5, C127E8, C127V, A31E5, A31E8,
and A31V, were tested for anchorage-independent
growth in soft agar. Cells (1 3 105) were resuspended in
3 ml of medium containing 0.3% Noble Agar (Difco, De-
troit, MI) and plated onto the top of the bottom layer of
0.5% Noble Agar in medium. PDGF (R & D Systems; No.
120-HD) at a concentration of 12.5 ng/ml was added to
the medium. Cells were fed twice weekly with 1 ml of
medium and scored for colony formation after 4 weeks.
Colonies of cells whose diameter was $5 times larger
than that of an individual cell were counted.
Tumorigenesis assays
Cells were collected at logarithmic phase and sus-
pended in PBS. Cells (5 3 106) in 0.1 ml of PBS were
injected subcutaneously into nude mice (6–8 weeks old).
Each C127 transfectant line was injected into three nude
mice, and cells from each A31 transfectant line was
injected into two nude mice. Tumors were scored in 4–8
weeks. Mice were killed and tumors were photographed
at 8 weeks.
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